No Carolina / NY / Florida
Ph: 561.316.3330

HomeMEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Category: MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

SonoVascular Enters Into Strategic Collaboration...

"SonoVascular is honored to have the opportunity to partner with Lantheus, a leader in microbubble development," said Daniel Estay, Founder and Chief Executive Officer of SonoVascular. "Our SonoThrombectomy System, combined with Lantheus' microbubbles, is designed to provide a true, next-generation solution for the treatment of DVT and PE that overcomes the drawbacks associated with catheter-based thrombectomy and thrombolysis devices."

Anaut Announces Japanese Regulatory Approval...

Eureka α utilizes state-of-the-art AI to analyze real-time video from laparoscopic and robotic surgery, enhancing surgeons' accuracy by highlighting the dissection planes characterized by connective tissue.

SonoVascular Enters Into Strategic Collaboration with Lantheus Holdings | for Use of Microbubbles in Combination with SonoThrombectomy™ System for Treatment of Venous Thromboembolism

"SonoVascular is honored to have the opportunity to partner with Lantheus, a leader in microbubble development," said Daniel Estay, Founder and Chief Executive Officer of SonoVascular. "Our SonoThrombectomy System, combined with Lantheus' microbubbles, is designed to provide a true, next-generation solution for the treatment of DVT and PE that overcomes the drawbacks associated with catheter-based thrombectomy and thrombolysis devices."

MolecuLight Reports United States Patent and Trademark Office Cancels All Claims of Swift Medical’s Patent

The decision cancels each of the original claims of the '345 Patent and declares unpatentable each of Swift's proposed substitute claims. Amongst the prior art deemed by the USPTO to render the '345 Patent unpatentable is a patent application licensed to MolecuLight that lists MolecuLight's Founder, Dr. Ralph DaCosta, as the sole inventor.

Kaleido Launches Cutting-edge Hybrid Closed Loop system with Diabeloop and Dexcom for People with Diabetes

It combines the convenience of the Kaleido insulin pump with two market-leading innovations designed by Diabeloop and Dexcom to create a Hybrid Closed Loop system for managing type 1 diabetes which is flexible, self-learning and easy to use.

Biocomposites Expands Product Portfolio | Launches SYNICEM Spacers in the UK

SYNICEM spacers are antibiotic-loaded, preformed spacers which overcome the challenges of traditional intra-operative moulded and handmade spacers. They help support surgeons' revisions of the hip, knee and shoulder by preserving articular space and aiding the treatment of infection.

PathKeeper Surgical Celebrates the First Spine Surgery Performed with the PathKeeper 3D Optical Navigation System in Massachusetts

The PathKeeper system was used at Southcoast Health's St. Luke's Hospital in New Bedford, MA, to improve the clinical experience, increase surgical accuracy and eliminate radiation exposure during surgery.

BD Advances “One-Stick Hospital Stay” Vision with Launch of Next-Generation Needle-Free Blood Draw Technology

With 510(k) clearance from the U.S. Food and Drug Administration (FDA), the new PIVO™ Pro Needle-free Blood Collection Device features design improvements to achieve the first and only compatibility with integrated and long peripheral IV catheters, including the new Nexiva™ Closed IV Catheter System with NearPort™ IV Access. This expands on current PIVO™ compatibility with traditional short peripheral IV catheters available since 2017.  

Ceribell Launches ClarityPro ™ AI, Expanding Access to Critical Diagnosis of Electrographic Status Epilepticus

ClarityPro is an AI-based software algorithm within the Ceribell EEG system that analyzes EEG waveforms to diagnose electrographic status epilepticus (ESE). It is the first acute care device to be FDA indicated for stand-alone diagnosis.

Medical Equipment Upgrades in the Dental Space: Revolutionizing Patient Care

In this article, we will explore the latest innovations in the dental space and delve into the importance of autoclaves in maintaining a safe and sterile environment.

Study Organized by Main Line Health Researchers Reverses FDA Warning on Vital Peripheral Artery Disease Treatment

Results of the study on devices coated with paclitaxel were presented today at the TCT 2023 meeting in San Francisco, the world’s largest interventional cardiology meeting. The study shows no increased risk of death from use of paclitaxel-coated devices and has simultaneously been published on a fast-track basis by The Lancet.

PeekMed Expands into the US with a New Subsidiary and New Product

The decision to form PeekMed LLC is driven by a desire to strengthen presence in the world's largest and most influential healthcare market. This expansion will enable PeekMed to offer versatile solutions and provide timely support to its growing customer base in the US.

By using this website you agree to accept Medical Device News Magazine Privacy Policy